Lactoferrin 1 11
Alternative Names: hLF 1-11Latest Information Update: 26 Aug 2015
Price :
$50 *
At a glance
- Originator AM-Pharma Holding
- Developer AM-Pharma
- Class Antibacterials; Peptides
- Mechanism of Action Chelating agents; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Bacteraemia; Bacterial infections; Candidaemia; Mycoses
Most Recent Events
- 01 Oct 2007 Data presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapeutics (ICAAC-2007) added to the Bacterial Infections and Mycoses antimicrobial activity and pharmacodynamics sections
- 30 Oct 2006 Data presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2006) have been added to the Mycoses pharmacodynamics section
- 10 Aug 2006 Phase-II clinical trials in Mycoses in Netherlands (Injection)